Insmed (INSM) Misses Q3 EPS by 41c, provide guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $117.83 -3.06%
Revenue Growth %: +253.0%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +253.0%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.75), $0.41 worse than the analyst estimate of ($1.34). Revenue for the quarter came in at $142 million versus the consensus estimate of $114.87 million.
GUIDANCE:
Insmed sees FY2025 revenue of $420-430 million, versus the consensus of $471.3 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- ShinyHunters hackers say they stole psychiatric and medical records of DBI staff - Reuters
- NeuroSense posts narrower H1 loss, targets Canada drug filing by December
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
